雕镂
发表于 2025-3-23 12:04:52
Clinical Implications of Epigenetic Alterations in Lung Cancer,
conservative
发表于 2025-3-23 17:00:29
Epigenetic Therapies in Solid Tumours: From Preclinical Models to Clinical Trial Results,
Bph773
发表于 2025-3-23 20:57:24
th present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.978-3-662-51928-8978-3-642-38404-2
scrape
发表于 2025-3-23 22:12:06
http://reply.papertrans.cn/32/3133/313225/313225_14.png
GUISE
发表于 2025-3-24 05:32:33
Michael Lübbert,Peter A. JonesDevotes detailed attention to the translation of basic research and drug development to clinical applications in the treatment of solid tumors as well as hematologic malignancies and hemoglobinopathy.
Immobilize
发表于 2025-3-24 07:26:43
http://image.papertrans.cn/e/image/313225.jpg
PUT
发表于 2025-3-24 14:10:10
978-3-662-51928-8Springer-Verlag Berlin Heidelberg 2014
Peristalsis
发表于 2025-3-24 15:24:58
http://reply.papertrans.cn/32/3133/313225/313225_18.png
Anticlimax
发表于 2025-3-24 19:21:59
http://reply.papertrans.cn/32/3133/313225/313225_19.png
placebo
发表于 2025-3-25 03:03:25
Book 2014roaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epi